A clinical study for Idiopathic Pulmonary Fibrosis (IPF)
Novartis is enrolling adults with IPF in a study. They are testing the safety and effectiveness of a new medication. There are various locations throughout the US. You can contact a study site here or click here to find more detailed information in www.clinicaltrials.gov.